Home Tags HPLN

Tag: HPLN

NanoValent Receives NIH SBIR Funding for Ongoing Development of Antibody-conjugated Nanoparticle...

The National Institute of Health's (NIH) Small Business Innovation Research (SBIR) Program has confirmed that it has awarded first year funding for two separate...

NanoValent Pharmaceuticals and Children’s Hospital Los Angeles Sign Exclusive Global Licensing...

Earlier today, NanoValent Pharmaceuticals, a privately-held development-stage cancer-focused pharmaceutical company advancing antibody-drug conjugate or ADC therapeutics, confirmed signing a licensing agreement with Children's Hospital...